Joshua Hexter - 02 Jan 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
COO & CBO
Signature
/s/ Joshua Hexter
Issuer symbol
ORMP
Transactions as of
02 Jan 2025
Transactions value $
$0
Form type
4
Filing time
06 Jan 2025, 16:10:08 UTC
Previous filing
08 Nov 2024
Next filing
11 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award +195K +38% 706K 02 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 16,208 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.